Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

drug-induced lupus erythematosus (DIL) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

drug-induced lupus erythematosus

MONDO:0016474

Also known as:DILDILEdrug induced lupus

Overview

An autoimmune disorder, similar to systemic lupus erythematosus, that is caused by certain drugs.

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

Features include very common findings: Blood in the urine (hematuria), Petechiae, Pericardial effusion, and Pericarditis and others; and common findings: Fever and Serositis. 23 total HPO annotations.

Organ System	Phenotype Count	Example Features
Lab test results	4	Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Antinuclear antibody positivity, Elevated CRP (inflammation marker) (elevated circulating c-reactive protein concentration)

Prognosis

Phenotype severity distribution: 20 very common features, 2 common features.

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for drug-induced lupus erythematosus.

58 publications have been identified in PubMed for drug-induced lupus erythematosus. Research spans Case Report / Case Series (64%), Review / Meta-Analysis (16%), and Epidemiology / Natural History (9%).

Research Type	Count	% of Total
Patient case studies	37	64%

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:50 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:231111

GARD

Genetic and Rare Diseases Info Center

GARD:20599

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Kisho

drug-induced lupus erythematosus

Overview

Clinical Presentation

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features

Recent Publications

drug-induced lupus erythematosus

Overview

Clinical Presentation

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features

Recent Publications